Anifrolumabbelimumabrituximabrituximab-treatedsystemic lupus erythematosusSLE
…plained approximately 8% of the variance in δCLASI (R2 = 0.08). Anifrolumab was the only therapy independently associated with significant …
1articles mentioning drugs
1drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: rituximab-treated ×
rituximab-treated
This drug is selected. Its supporting articles are shown below.